TY - JOUR
T1 - Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer
AU - Ripa, Rasmus Sejersten
AU - Katballe, Niels
AU - Wikman, Friedrik
AU - Jäger, Anne Charlotte
AU - Bernstein, Inge
AU - Orntoft, Torben
AU - Schwartz, Marianne
AU - Nielsen, Finn Cilius
AU - Bisgaard, Marie Luise
PY - 2005/2/15
Y1 - 2005/2/15
N2 - The diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is often confirmed by a mutation in one of several mismatch-repair genes, in particular MLH1, MSH2 and MSH6. Presymptomatic diagnosis requires the identification of a mutation causing the disease. Three different deletions of a single amino acid codon have previously been published as assumed pathogenic. The objective of this study was to determine if an MSH2 3 base pair in-frame deletion (N596del) could be used in presymptomatic screening of at-risk individuals. We report on five HNPCC families with the N596del mutation, identified after mutation screening of MSH2 and MLH1. All patients in the families were haplotyped using markers flanking the MSH2 gene. The haplotypes revealed that the five families with high probability descended from only two founders. The N596del segregated with the HNPCC phenotype with lod scores of 3.2 and 2.0 at the recombination fraction of 0.0 in the two founder families. Sequencing of MSH2 and MLH1 did not reveal other pathogenic mutations, and N596del was not identified in 50 healthy controls. The mutation has previously been found expressed in mRNA, and is located in a conserved domain. The results support the hypothesis that N596del is the disease causing mutation and not a clinically silent variation. On this basis, the application of the MSH2 N596del mutation, in presymptomatic screening of HNPCC families, is recommended.
AB - The diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is often confirmed by a mutation in one of several mismatch-repair genes, in particular MLH1, MSH2 and MSH6. Presymptomatic diagnosis requires the identification of a mutation causing the disease. Three different deletions of a single amino acid codon have previously been published as assumed pathogenic. The objective of this study was to determine if an MSH2 3 base pair in-frame deletion (N596del) could be used in presymptomatic screening of at-risk individuals. We report on five HNPCC families with the N596del mutation, identified after mutation screening of MSH2 and MLH1. All patients in the families were haplotyped using markers flanking the MSH2 gene. The haplotypes revealed that the five families with high probability descended from only two founders. The N596del segregated with the HNPCC phenotype with lod scores of 3.2 and 2.0 at the recombination fraction of 0.0 in the two founder families. Sequencing of MSH2 and MLH1 did not reveal other pathogenic mutations, and N596del was not identified in 50 healthy controls. The mutation has previously been found expressed in mRNA, and is located in a conserved domain. The results support the hypothesis that N596del is the disease causing mutation and not a clinically silent variation. On this basis, the application of the MSH2 N596del mutation, in presymptomatic screening of HNPCC families, is recommended.
KW - Adult
KW - Base Sequence
KW - Codon
KW - Colorectal Neoplasms, Hereditary Nonpolyposis
KW - DNA
KW - DNA-Binding Proteins
KW - Female
KW - Haplotypes
KW - Humans
KW - Male
KW - Middle Aged
KW - Molecular Sequence Data
KW - MutS Homolog 2 Protein
KW - Mutation
KW - Pedigree
KW - Proto-Oncogene Proteins
KW - Sequence Deletion
U2 - 10.1016/j.mrfmmm.2004.10.002
DO - 10.1016/j.mrfmmm.2004.10.002
M3 - Journal article
C2 - 15680406
SN - 0027-5107
VL - 570
SP - 89
EP - 96
JO - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
JF - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
IS - 1
ER -